Shefferman Jesse: insider trades.
Shefferman Jesse reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($882K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- Shefferman Jesse
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Protara Therapeutics, Inc. (TARA) | Director, Officer · CEO and President | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Protara Therapeutics, Inc. | G | 4,000 | $0 | 696,832 | Form 4 |
| 2026-06-30 | Protara Therapeutics, Inc. | G | 5,000 | $0 | 691,832 | Form 4 |
| 2026-06-30 | Protara Therapeutics, Inc. | G | 7,000 | $0 | 700,832 | Form 4 |
| 2026-06-30 | Protara Therapeutics, Inc. | G | 14,000 | $0 | 707,832 | Form 4 |
| 2026-06-29 | Protara Therapeutics, Inc. | M | 215,687 | $1.91 | 937,519 | Form 4 |
| 2026-06-29 | Protara Therapeutics, Inc. | S | 215,687 | $4.09 | 721,832 | Form 4 |
Questions
What stock did Shefferman Jesse buy or sell?
Shefferman Jesse reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($882K), across 1 company.
Is Shefferman Jesse the same person as other filers with this name?
This page covers SEC CIK 1799167 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/shefferman-jesse-1799167.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.